These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17484803)

  • 21. Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancer.
    Woods AM; Wang WW; Shaw DM; Ward CM; Carroll MW; Rees BR; Stern PL
    Biochem J; 2002 Aug; 366(Pt 1):353-65. PubMed ID: 12003637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies.
    Atreya I; Neurath MF
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):561-72. PubMed ID: 18402523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies in cancer immunotherapy.
    Reisfeld RA
    Clin Lab Med; 1992 Jun; 12(2):201-16. PubMed ID: 1611818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging the immune response to monitor tumor immunotherapy.
    Wang Q; Ornstein M; Kaufman HL
    Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-associated antigens and biomarkers in cancer and immune therapy.
    Malyankar UM
    Int Rev Immunol; 2007; 26(3-4):223-47. PubMed ID: 17558745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic immune response induced by intratumoral expression of the fusogenic membrane protein of vesicular stomatitis virus and cytokines encoded by adenoviral vectors.
    Hoffmann D; Bayer W; Wildner O
    Int J Mol Med; 2007 Nov; 20(5):673-81. PubMed ID: 17912460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of cell engineering technology to the tumour immunotherapeutic drug: a review.
    Chen ZN; Xing JL; Bian HJ; Mi L; Jiang JL
    Cell Biol Int; 2001; 25(10):1013-5. PubMed ID: 11589619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibody therapy for solid tumors.
    Green MC; Murray JL; Hortobagyi GN
    Cancer Treat Rev; 2000 Aug; 26(4):269-86. PubMed ID: 10913382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccines to treat cancer--an old approach whose time has arrived.
    Hellstrom KE; Hellstrom I
    J Cell Biochem; 2007 Oct; 102(2):291-300. PubMed ID: 17729239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotherapy of cancer.
    Harris DT; Mastrangelo MJ
    Semin Oncol; 1989 Jun; 16(3):180-98. PubMed ID: 2658082
    [No Abstract]   [Full Text] [Related]  

  • 31. New developments in the use of cytokines for cancer therapy.
    Maini A; Morse PD; Wang CY; Jones RF; Haas GP
    Anticancer Res; 1997; 17(5B):3803-8. PubMed ID: 9427784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible applications of antibodies or their genes in cancer therapy.
    Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M
    Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective tumor targeting: strategies for the delivery of Armed Antibodies.
    MacDonald GC; Glover N
    Curr Opin Drug Discov Devel; 2005 Mar; 8(2):177-83. PubMed ID: 15782542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human tumour-associated antigens: targets for monoclonal antibody-mediated cancer therapy.
    Reisfeld RA; Cheresh DA
    Cancer Surv; 1985; 4(1):271-90. PubMed ID: 3916082
    [No Abstract]   [Full Text] [Related]  

  • 35. Dendritic cells in cancer immunotherapy.
    Vulink A; Radford KJ; Melief C; Hart DN
    Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer vaccines: pessimism in check.
    Mocellin S; Mandruzzato S; Bronte V; Marincola FM
    Nat Med; 2004 Dec; 10(12):1278-9; author reply 1279-80. PubMed ID: 15580242
    [No Abstract]   [Full Text] [Related]  

  • 38. New, exciting developments in experimental therapies in the early 21st century.
    Los M
    Eur J Pharmacol; 2009 Dec; 625(1-3):1-5. PubMed ID: 19825369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of CAGE, a novel cancer/testis antigen, in various cellular processes, including tumorigenesis, cytolytic T lymphocyte induction, and cell motility.
    Kim Y; Jeoung D
    J Microbiol Biotechnol; 2008 Mar; 18(3):600-10. PubMed ID: 18388483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active immunization of human cancer with tumor cell-associated carbohydrate antigen.
    Adachi M; Inui Y; Suzuki Y; Ietomi K; Orimo K; Kobayashi S; Joshita T; Arai T; Matsumoto J; Okano A
    Anticancer Res; 1989; 9(2):309-12. PubMed ID: 2473694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.